Andrea Lynn Maria Silber MD

Associate Clinical Professor of Medicine (Medical Oncology)

Clinical Interests

breast cancer, particularly breast cancer in younger women, and the differences in breast cancer in diverse populations.


Board Certifications

1984
Internal Medicine, Board Certified
1991
Medical Oncology, Board Certified

Patient Care Locations

andrea_silberfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Breast - Female and Breast - MaleClinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
Cancer, Breast - Female, and Breast - MalePhase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer (S1207)
Breast - Female and Breast - MaleA Randomized, Multicenter, Open-label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine versus Trastuzumab as Adjuvant Therapy for Patients with HER2-Positive Primary Breast Cancer who have Residual Tumor Present Pathologically in the Breast or Axillary Lymph Nodes following Preoperative Therapy (NSABP B50/Katherine Study)
Breast - Female and Breast - MaleA Phase II Study with Orteronel as Monotherapy in Patients with Metastatic Breast Cancer (MBC) that Expresses the Androgen Receptor (AR)
Breast - FemaleA neoadjuvant phase II trial of aromatase inhibitors in combination with everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancers with low and intermediate risk (less than or equal to 25) Oncoptype Dx Recurrence Scores

More Clinical Trials...

Edit Profile